The Office of Pediatric Therapeutics, Food and Drug Administration (FDA), is announcing a public workshop entitled ``Advancing the Development of Pediatric Therapeutics (ADEPT): Application of ``Big Data'' to Pediatric Safety Studies.'' The purpose of this 2-day workshop is to understand how to access and analyze ``Big Data'' associated with safety information in the health care setting, and the utility and challenges associated with the use of ``Big Data'' to study the safety of therapeutics in children.
Document
Advancing the Development of Pediatric Therapeutics: Application of “Big Data” to Pediatric Safety Studies; Public Workshop
The Office of Pediatric Therapeutics, Food and Drug Administration (FDA), is announcing a public workshop entitled ``Advancing the Development of Pediatric Therapeutics (ADEPT):...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 40005
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Advancing the Development of Pediatric Therapeutics: Application of “Big Data” to Pediatric Safety Studies; Public Workshop,” thefederalregister.org (August 23, 2017), https://thefederalregister.org/documents/2017-17783/advancing-the-development-of-pediatric-therapeutics-application-of-big-data-to-pediatric-safety-studies-public-workshop.